Helicobacter pylori infection
Conditions
Interventions
Sponsors
Sichuan Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) Age 18-70 2) Treatment failure of Hp infection >=4 times with standard treatment regimen 3) Patients with early gastric cancer, peptic ulcer, gastric MALT lymphoma, atrophic gastritis and other diseases requiring the eradication of Hp
Exclusion criteria
Exclusion criteria: 1) Antibiotics and bismuth were taken within 4 weeks before this treatment; Or had taken PPI, H2 receptor antagonist, P-CAB within 2 weeks prior to treatment; 2) Pregnant or lactating women; 3) Those who are allergic to the investigational drugs used in this test or have contraindications; 4) Participated in other drug trials within 3 months before the treatment of this trial; 5) There are other serious diseases that affect the evaluation of this study at the same time, or they cannot correctly express their own complaints and cannot cooperate; 6) Subjects with dysphagia; 7) Patients with malignant tumors, serious concomitant diseases, severe ulcer bleeding or perforation; 8) Patients judged by the investigator to be unsuitable for clinical trials. 9) Those who do not want to sign the informed consent for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hp eradication rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions; | — |
Countries
China
Contacts
Public ContactCaiping Gao
Sichuan Provincial People's Hospital
Outcome results
None listed